<version>
  <xmlsource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Quality Measures Clearinghouse (NQMC).</xmlsource>
  <section secid="560" ordby="10" name="General">
    <field fieldid="11" ordby="20" id="561" name="Title" type="text">
      <fieldvalue value="<div class=&quot;content_title&quot;>Upper gastrointestinal (GI) cancer: proportion of patients with oesophageal or gastric cancer who have tumour node metastases (TNM) stage and treatment intent recorded at a multidisciplinary team (MDT) meeting prior to treatment.</div>"/>
    </field>
    <field fieldid="1" ordby="30" id="562" name="Source(s)" type="citation">
      <fieldvalue value="<table><tr><td>NHS Scotland, Scottish Cancer Taskforce. Upper GI cancer clinical quality performance indicators. Edinburgh (Scotland): Healthcare Improvement Scotland, Scottish Government; 2015 Jan. 41 p.  [15 references]</td></tr></table>"/>
    </field>
  </section>
  <section secid="563" ordby="40" name="Measure Domain">
    <field fieldid="3025" ordby="50" id="564" name="Primary Measure Domain" type="picklist-one">
      <fieldvalue value="Clinical Quality Measures: Process"/>
    </field>
    <field fieldid="3026" ordby="60" id="565" name="Secondary Measure Domain" type="picklist-one">
      <fieldvalue value="Related Health Care Delivery Measure: Management"/>
    </field>
  </section>
  <section secid="566" ordby="70" name="Brief Abstract">
    <field fieldid="34" ordby="80" id="567" name="Description" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>This measure is used to assess the proportion of patients with oesophageal or gastric cancer who have tumour node metastases (TNM) stage and treatment intent recorded at a multidisciplinary team (MDT) meeting prior to treatment. </p>
<p class=&quot;Note&quot;><strong>Note from the National Quality Measures Clearinghouse</strong>: This measure is part of the Cancer Quality Performance Indicators (QPIs) collection. For more information, including a complete list of QPI measure sets, please visit the <a href=&quot;http://www.healthcareimprovementscotland.org/our_work/cancer_care_improvement/cancer_qpis.aspx&quot; title=&quot;Healthcare Improvement Scotland Web site&quot;>Healthcare Improvement Scotland Web site</a>.</p></div>"/>
    </field>
    <field fieldid="21" ordby="90" id="568" name="Rationale" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>It is important to discuss and consider treatment intent as patients with incurable disease treated as radical will be poorly served. </p>
<p>Patients with gastric or oesophageal cancer should undergo careful staging to assess the extent of disease and inform treatment decision making (Scottish Intercollegiate Guidelines Network [SIGN], 2006). This may involve multiple investigations. </p>
<p>Clinical staging should follow the principles of tumour node metastases (TNM) classification (The Royal College of Pathologists, 2007); this aids the determination of prognosis and choice of therapy. A statement regarding clinical stage and treatment intent should be recorded at the multidisciplinary team (MDT) meeting. For patients presenting with metastatic disease it is not always possible or appropriate to determine T and N stage. Within the Cancer Quality Performance Indicator (QPI) T<sub>x</sub>N<sub>x</sub>M<sub>1</sub>* is therefore accepted as complete staging in this situation.</p>
<p class=&quot;Note&quot;>*Patients presenting with stage T<sub>x</sub>N<sub>x</sub>M<sub>1</sub> disease have metastatic cancer where the extent of primary tumour or lymph node involvement cannot be assessed. </p></div>"/>
    </field>
    <field fieldid="3500" ordby="100" id="569" name="Evidence for Rationale" type="citation">
      <fieldvalue value="<table><tr><td>NHS Scotland, Scottish Cancer Taskforce. Upper GI cancer clinical quality performance indicators. Edinburgh (Scotland): Healthcare Improvement Scotland, Scottish Government; 2015 Jan. 41 p.  [15 references]</td></tr></table>"/>
      <fieldvalue value="<table><tr><td>Scottish Intercollegiate Guidelines Network (SIGN). Management of oesophageal and gastric cancer. A national clinical guideline. Edinburgh (Scotland): Scottish Intercollegiate Guidelines Network (SIGN); 2006 Jun. 69 p.&amp;nbsp;(SIGN publication; no. 87).&amp;nbsp; [393 references]</td></tr></table>"/>
      <fieldvalue value="<table><tr><td>The Royal College of Pathologists. Dataset for the histopathological reporting of gastric carcinoma, 2nd edition. London (UK): The Royal College of Pathologists; 2007 Jan. 15 p. </td></tr></table>"/>
    </field>
    <field fieldid="3022" ordby="110" id="570" name="Primary Health Components" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Oesophageal cancer; gastric cancer; tumour node metastases (TNM) stage; treatment intent; multidisciplinary team (MDT) meeting </p></div>"/>
    </field>
    <field fieldid="23" ordby="120" id="571" name="Denominator Description" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>All patients with oesophageal or gastric cancer </p></div>"/>
    </field>
    <field fieldid="24" ordby="130" id="572" name="Numerator Description" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Number of patients with oesophageal or gastric cancer who have tumour node metastases (TNM) stage and treatment intent recorded at a multidisciplinary team (MDT) meeting prior to treatment (see the related &quot;Numerator Inclusions/Exclusions&quot; field)</p></div>"/>
    </field>
  </section>
  <section secid="573" ordby="140" name="Evidence Supporting the Measure">
    <field fieldid="3027" ordby="150" id="574" name="Type of Evidence Supporting the Criterion of Quality for the Measure" type="picklist-choice">
      <fieldvalue value="A clinical practice guideline or other peer-reviewed synthesis of the clinical research evidence"/>
      <fieldvalue value="A formal consensus procedure, involving experts in relevant clinical, methodological,  public health and organizational sciences"/>
    </field>
    <field fieldid="3501" ordby="160" id="575" name="Additional Information Supporting Need for the Measure" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Unspecified</p></div>"/>
    </field>
    <field fieldid="3072" ordby="180" id="577" name="Extent of Measure Testing" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>The collection of data is piloted on a small number of patient records using a paper data collection form produced by the Information Services Division (ISD). The aim is to identify any anomalies or difficulties with data collection prior to full implementation. At least one NHS board in each Regional Cancer Network participates in the pilot.</p></div>"/>
    </field>
    <field fieldid="3007" ordby="190" id="578" name="Evidence for Extent of Measure Testing" type="citation">
      <fieldvalue value="<table><tr><td>NHS Scotland. National cancer quality performance indicators: overview of development process. Edinburgh (Scotland): NHS Scotland; 2012 Dec. 7 p. </td></tr></table>"/>
    </field>
  </section>
  <section secid="580" ordby="210" name="State of Use of the Measure">
    <field fieldid="3029" ordby="220" id="581" name="State of Use" type="picklist-one">
      <fieldvalue value="Current routine use"/>
    </field>
    <field fieldid="3030" ordby="230" id="582" name="Current Use" type="picklist-choice-3">
      <fieldvalue value="not defined yet"/>
    </field>
  </section>
  <section secid="583" ordby="240" name="Application of the Measure in its Current Use">
    <field fieldid="3031" ordby="250" id="584" name="Measurement Setting" type="picklist-choice">
      <fieldvalue value="Ambulatory/Office-based Care"/>
      <fieldvalue value="Hospital Inpatient"/>
      <fieldvalue value="Hospital Outpatient"/>
    </field>
    <field fieldid="3032" ordby="260" id="585" name="Professionals Involved in Delivery of Health Services" type="picklist-choice-3">
      <fieldvalue value="not defined yet"/>
    </field>
    <field fieldid="3033" ordby="270" id="586" name="Least Aggregated Level of Services Delivery Addressed" type="picklist-one">
      <fieldvalue value="Single Health Care Delivery or Public Health Organizations"/>
    </field>
    <field fieldid="3505" ordby="280" id="587" name="Statement of Acceptable Minimum Sample Size" type="picklist-one">
      <fieldvalue value="Unspecified"/>
    </field>
    <field fieldid="41" ordby="290" id="588" name="Target Population Age" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Unspecified</p></div>"/>
    </field>
    <field fieldid="42" ordby="300" id="589" name="Target Population Gender" type="picklist-one">
      <fieldvalue value="Either male or female"/>
    </field>
  </section>
  <section secid="660" ordby="310" name="National Strategy for Quality Improvement in Health Care">
    <field fieldid="3522" ordby="320" id="661" name="National Quality Strategy Aim" type="text">
      <fieldvalue value="<ul><li>Better Care</li></ul>"/>
    </field>
    <field fieldid="3525" ordby="330" id="662" name="National Quality Strategy Priority" type="text">
      <fieldvalue value="<ul><li>Prevention and Treatment of Leading Causes of Mortality</li></ul>"/>
    </field>
  </section>
  <section secid="590" ordby="340" name="Institute of Medicine (IOM) National Health Care Quality Report Categories">
    <field fieldid="3163" ordby="350" id="591" name="IOM Care Need" type="picklist-choice">
      <fieldvalue value="Living with Illness"/>
    </field>
    <field fieldid="3164" ordby="360" id="592" name="IOM Domain" type="picklist-choice">
      <fieldvalue value="Effectiveness"/>
    </field>
  </section>
  <section secid="593" ordby="370" name="Data Collection for the Measure">
    <field fieldid="3506" ordby="380" id="594" name="Case Finding Period" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Unspecified</p></div>"/>
    </field>
    <field fieldid="3054" ordby="390" id="595" name="Denominator Sampling Frame" type="picklist-one">
      <fieldvalue value="Patients associated with provider"/>
    </field>
    <field fieldid="3057" ordby="400" id="598" name="Denominator (Index) Event or Characteristic" type="picklist-choice">
      <fieldvalue value="Clinical Condition"/>
    </field>
    <field fieldid="3058" ordby="410" id="599" name="Denominator Time Window" type="picklist-choice-3">
      <fieldvalue value="not defined yet"/>
    </field>
    <field fieldid="55" ordby="420" id="596" name="Denominator Inclusions/Exclusions" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p><strong>Inclusions</strong><br />
All patients with oesophageal or gastric cancer</p>
<p><strong>Exclusions</strong><br />
None </p></div>"/>
    </field>
    <field fieldid="3507" ordby="430" id="597" name="Exclusions/Exceptions" type="picklist-choice-4">
      <fieldvalue value="not defined yet"/>
    </field>
    <field fieldid="59" ordby="440" id="600" name="Numerator Inclusions/Exclusions" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p><strong>Inclusions</strong><br />
Number of patients with oesophageal or gastric cancer who have tumour node metastases (TNM)* stage and treatment intent recorded at a multidisciplinary team (MDT) meeting prior to treatment</p>
<p class=&quot;Note&quot;><strong>Note</strong>: <em>MDT Meeting</em>: A meeting which is held on a regular basis, which is made up of participants from various disciplines appropriate to the disease area, where diagnosis, management, and appropriate treatment of patients is discussed and decided. </p>
<p class=&quot;Note&quot;>*TNM classification is a system for staging the extent of cancer. T describes the size of the tumour. N refers to the involvement of the lymph nodes. M refers to the presence of metastatic disease.</p>
<p><strong>Exclusions</strong><br />
None </p></div>"/>
    </field>
    <field fieldid="3061" ordby="450" id="601" name="Numerator Search Strategy" type="picklist-one">
      <fieldvalue value="Fixed time period or point in time"/>
    </field>
    <field fieldid="3062" ordby="460" id="602" name="Data Source" type="picklist-many">
      <fieldvalue value="Electronic health/medical record"/>
      <fieldvalue value="Paper medical record"/>
    </field>
    <field fieldid="3065" ordby="470" id="603" name="Type of Health State" type="picklist-one">
      <fieldvalue value="Does not apply to this measure"/>
    </field>
    <field fieldid="3066" ordby="480" id="604" name="Instruments Used and/or Associated with the Measure" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Unspecified</p></div>"/>
    </field>
  </section>
  <section secid="605" ordby="490" name="Computation of the Measure">
    <field fieldid="3508" ordby="500" id="606" name="Measure Specifies Disaggregation" type="picklist-one">
      <fieldvalue value="Measure is disaggregated into categories based on different definitions of the denominator and/or numerator"/>
    </field>
    <field fieldid="3509" ordby="510" id="607" name="Basis for Disaggregation" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>This indicator will be additionally be reported separately for tumour node metastases (TNM) stage and treatment intent to allow for easy identification of key quality issues and further sub-analysis where required. </p></div>"/>
    </field>
    <field fieldid="3067" ordby="520" id="608" name="Scoring" type="picklist-many">
      <fieldvalue value="Rate/Proportion"/>
    </field>
    <field fieldid="3068" ordby="530" id="609" name="Interpretation of Score" type="picklist-one">
      <fieldvalue value="Desired value is a higher score"/>
    </field>
    <field fieldid="3090" ordby="540" id="610" name="Allowance for Patient or Population Factors" type="picklist-choice-3">
      <fieldvalue value="not defined yet"/>
    </field>
    <field fieldid="3070" ordby="560" id="612" name="Standard of Comparison" type="picklist-choice-3">
      <fieldvalue value="not defined yet"/>
    </field>
    <field fieldid="71" ordby="570" id="613" name="Prescriptive Standard" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p><strong>Target</strong>: 95% </p>
<p>The tolerance within this target accounts for situations where patients are not fit enough to undergo investigations and/or treatment; however, in these cases an attempt at tumour node metastases (TNM) staging should be undertaken based on the information available. </p></div>"/>
    </field>
    <field fieldid="9" ordby="580" id="614" name="Evidence for Prescriptive Standard" type="citation">
      <fieldvalue value="<table><tr><td>NHS Scotland, Scottish Cancer Taskforce. Upper GI cancer clinical quality performance indicators. Edinburgh (Scotland): Healthcare Improvement Scotland, Scottish Government; 2015 Jan. 41 p.  [15 references]</td></tr></table>"/>
    </field>
  </section>
  <section secid="615" ordby="590" name="Identifying Information">
    <field fieldid="73" ordby="600" id="616" name="Original Title" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>QPI 4 &amp;ndash; staging and treatment intent. </p></div>"/>
    </field>
    <field fieldid="74" ordby="610" id="617" name="Measure Collection Name" type="text">
      <fieldvalue value="Cancer Quality Performance Indicators (QPIs)"/>
    </field>
    <field fieldid="75" ordby="620" id="618" name="Measure Set Name" type="text">
      <fieldvalue value="Upper GI Cancer"/>
    </field>
    <field fieldid="77" ordby="630" id="619" name="Measure Subset Name" type="text">
      <fieldvalue value="Diagnosis and Staging QPIs"/>
    </field>
    <field fieldid="16" ordby="650" id="621" name="Submitter" type="orglist">
      <fieldvalue value="NHS Scotland - National Government Agency [Non-U.S.]"/>
      <fieldvalue value="Scottish Cancer Taskforce - National Government Agency [Non-U.S.]"/>
    </field>
    <field fieldid="17" ordby="660" id="622" name="Developer" type="orglist-p">
      <fieldvalue value="NHS Scotland - National Government Agency [Non-U.S.]"/>
      <fieldvalue value="Scottish Cancer Taskforce - National Government Agency [Non-U.S.]"/>
    </field>
    <field fieldid="79" ordby="670" id="623" name="Funding Source(s)" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Scottish Government </p></div>"/>
    </field>
    <field fieldid="80" ordby="680" id="624" name="Composition of the Group that Developed the Measure" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Upper GI Cancer QPI Development Group </p></div>"/>
    </field>
    <field fieldid="81" ordby="690" id="625" name="Financial Disclosures/Other Potential Conflicts of Interest" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Unspecified</p></div>"/>
    </field>
    <field fieldid="19" ordby="730" id="629" name="Adaptation" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>This measure was not adapted from another source.</p></div>"/>
    </field>
    <field fieldid="3086" ordby="740" id="630" name="Date of Most Current Version in NQMC" type="date">
      <fieldvalue value="2015 Jan"/>
    </field>
    <field fieldid="3511" ordby="750" id="631" name="Measure Maintenance" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>The Cancer Quality Performance Indicators (QPIs) will be kept under regular review and be responsive to changes in clinical practice and emerging evidence.</p></div>"/>
    </field>
    <field fieldid="3512" ordby="760" id="632" name="Date of Next Anticipated Revision" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Unspecified</p></div>"/>
    </field>
    <field fieldid="20" ordby="770" id="633" name="Measure Status" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>This is the current release of the measure.</p></div>"/>
    </field>
    <field fieldid="14" ordby="780" id="634" name="Measure Availability" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Source document available from the <a href=&quot;http://www.healthcareimprovementscotland.org/our_work/cancer_care_improvement/cancer_qpis/quality_performance_indicators.aspx&quot; title=&quot;Healthcare Improvement Scotland Web site&quot;>Healthcare Improvement Scotland Web site</a>.</p>
<p>For more information, contact the Healthcare Improvement Scotland at Gyle Square, 1 South Gyle Crescent, Edinburgh, Scotland EH12 9EB; Phone: 0131 623 4300; E-mail: <a href=&quot;mailto:comments.his@nhs.net&quot;>comments.his@nhs.net</a>; Web site: <a href=&quot;http://www.healthcareimprovementscotland.org/&quot; title=&quot;Healthcare Improvement Scotland Web site&quot;>www.healthcareimprovementscotland.org/</a>.</p></div>"/>
    </field>
    <field fieldid="15" ordby="790" id="635" name="Companion Documents" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>The following is available:</p>
<ul style=&quot;list-style-type: disc;&quot;>
    <li>NHS Scotland. National cancer quality performance indicators: overview of development process. Edinburgh (Scotland): NHS Scotland; 2012 Dec. 7 p. This document is available from the <a href=&quot;http://www.healthcareimprovementscotland.org/our_work/cancer_care_improvement/cancer_qpis/quality_performance_indicators.aspx&quot; title=&quot;Healthcare Improvement Scotland Web site&quot;>Healthcare Improvement Scotland Web site</a>. </li>
</ul></div>"/>
    </field>
    <field fieldid="87" ordby="800" id="636" name="NQMC Status" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>This NQMC summary was completed by ECRI Institute on May 19, 2017.</p></div>"/>
    </field>
    <field fieldid="88" ordby="810" id="637" name="Copyright Statement" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>No copyright restrictions apply.</p></div>"/>
    </field>
  </section>
  <section secid="641" ordby="850" name="Production">
    <field fieldid="1" ordby="1366" id="562" name="Source(s)" type="citation">
      <fieldvalue value="<table><tr><td>NHS Scotland, Scottish Cancer Taskforce. Upper GI cancer clinical quality performance indicators. Edinburgh (Scotland): Healthcare Improvement Scotland, Scottish Government; 2015 Jan. 41 p.  [15 references]</td></tr></table>"/>
    </field>
  </section>
  <section secid="99999" ordby="99999" name="Disclaimer">
    <field fieldid="99999" ordby="99999" id="99999" name="NQMC Disclaimer" type="text">
      <fieldvalue value="<p>The National Quality Measures Clearinghouseâ„¢ (NQMC) does not develop, produce, approve, or endorse the measures represented on this site.</p> 
<p>All measures summarized by NQMC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public and private organizations, other government agencies, health care organizations or plans, individuals, and similar entities.</p> 
<p>Measures represented on the NQMC Web site are submitted by measure developers, and are screened solely to determine that they meet the <a href=&quot;/help-and-about/summaries/inclusion-criteria&quot;>NQMC Inclusion Criteria</a>.</p> 
<p>NQMC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or its reliability and/or validity of the quality measures and related materials represented on this site. Moreover, the views and opinions of developers or authors of measures represented on this site do not necessarily state or reflect those of NQMC, AHRQ, or its contractor, ECRI Institute, and inclusion or hosting of measures in NQMC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding measure content are directed to contact the measure developer.</p>"/>
    </field>
  </section>
</version><!--
     FILE ARCHIVED ON 03:36:46 Jul 06, 2017 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 23:09:08 Jul 15, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 432.611 (3)
  esindex: 0.006
  captures_list: 450.881
  CDXLines.iter: 13.861 (3)
  PetaboxLoader3.datanode: 49.17 (4)
  exclusion.robots: 0.196
  exclusion.robots.policy: 0.183
  RedisCDXSource: 1.06
  PetaboxLoader3.resolve: 714.267 (3)
  load_resource: 348.708
-->